Our data provide evidence that NFκB survival pathway is constitutively activated in PEL cells and that inhibition of this pathway negatively regulates down-stream anti-apoptotic and pro-survival targets of p65 subunit of NFκB. This evidence concerns the gene NFKB1 and primary effusion lymphoma.